Pharmacy Technology

BASEL, Switzerland Swiss drug maker Roche has bought the rights to an investigative treatment for hepatitis C, Roche said.

The company announced Thursday that it had purchased global development and commercialization rights to the drug RG7227/ITMN-191 (danoprevir) from InterMune for $175 million.

Roche said the drug had shown promise in preclinical and early clinical development. The two companies have been developing the drug since 2006.

PRINCETON, N.J. Arm & Hammer is helping cat owners fight litter box odors with its new Arm & Hammer Double Duty Clumping litter, designed to eliminate urine and feces odors.

NEW YORK CVS Caremark has no doubt been a trailblazer in the healthcare arena, positioning itself along the front lines to leverage its various points of care to improve outcomes and lower healthcare costs. But with all that CVS Caremark has done and will continue to do in the healthcare space -- and it is no doubt a lot -- it still has more than 7,000 retail locations, and the front of the store continues to be a critical part of its business and a major growth driver for the company.

CAMBRIDGE, Mass. The board of directors of Genzyme again has rejected a buyout offer by French drug maker Sanofi-Aventis, Genzyme said Thursday.

The biotech company’s board unanimously turned down the hostile offer Sanofi made Monday to acquire Genzyme for $18.5 billion, or $69 per share, saying it was “opportunistic” and undervalued the company.

ST. LOUIS Keeping up with the times, Energizer has launched a rechargeable case with built-in battery for the newest edition of the iPhone.